Synbio International, Inc. (SYIN)
OTCMKTS
· Delayed Price · Currency is USD
0.0014
-0.0001 (-6.67%)
Jun 13, 2025, 9:30 AM EDT
Synbio International Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
443.10K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2007 | 98.56K | -16.39K | -14.26% |
| Dec 31, 2006 | 114.95K | 925.00 | 0.81% |
| Dec 31, 2005 | 114.02K | - | - |
| Dec 31, 2004 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo, Inc. | 1.73B |
| Elite Pharmaceuticals | 70.00M |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Northwest Biotherapeutics | 1.47M |
| Glass House Brands | 215.62M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 27.70M |